sort of , but its only about 60ks worth. still looking and waitng for the research report.looks ok, but cash burn rate we indicate the need to get throught their phase 2 trails and prob raise some more cash .just like any biotech with new products
PV1 Provaris tells ASX non-binding MOUs are still material to share prices in somewhat fiery compliance response